NO960653L - A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient - Google Patents

A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Info

Publication number
NO960653L
NO960653L NO960653A NO960653A NO960653L NO 960653 L NO960653 L NO 960653L NO 960653 A NO960653 A NO 960653A NO 960653 A NO960653 A NO 960653A NO 960653 L NO960653 L NO 960653L
Authority
NO
Norway
Prior art keywords
progesterone
oral administration
excipient
polyethylene glycol
pharmaceutical agent
Prior art date
Application number
NO960653A
Other languages
Norwegian (no)
Other versions
NO960653D0 (en
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO960653D0 publication Critical patent/NO960653D0/en
Publication of NO960653L publication Critical patent/NO960653L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Farmasøytisk preparat for oral administrering av progesteron kan passende inneholde en PEG og en ytterligere eksipiens valgt fra gruppen som omfatter en stivelse, en cellulose, pektin og tragant.Pharmaceutical composition for oral administration of progesterone may suitably contain a PEG and a further excipient selected from the group comprising a starch, a cellulose, pectin and tragacanth.

NO960653A 1993-08-20 1996-02-19 A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient NO960653L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (en) 1993-08-20 1993-08-20 PHARMACEUTICAL FORMULA CONTAINING A HORMON
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (2)

Publication Number Publication Date
NO960653D0 NO960653D0 (en) 1996-02-19
NO960653L true NO960653L (en) 1996-02-19

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960653A NO960653L (en) 1993-08-20 1996-02-19 A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Country Status (17)

Country Link
EP (1) EP0789560A1 (en)
JP (1) JPH09501682A (en)
KR (1) KR960703570A (en)
CN (1) CN1132478A (en)
AU (1) AU7530594A (en)
BR (1) BR9407306A (en)
CA (1) CA2169840A1 (en)
CZ (1) CZ42596A3 (en)
DK (1) DK95093D0 (en)
FI (1) FI960749A7 (en)
HU (1) HUT74167A (en)
LT (1) LT4043B (en)
NO (1) NO960653L (en)
NZ (1) NZ271617A (en)
PL (1) PL313113A1 (en)
SK (1) SK19396A3 (en)
WO (1) WO1995005807A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (en) * 1997-12-19 2001-03-09 Besins Iscovesco Lab PROGESTERONE TABLET AND PROCESS FOR THE PREPARATION THEREOF
FR2775599B1 (en) * 1998-03-09 2001-08-17 Besins Iscovesco Lab PHARMACEUTICAL COMPOSITION BASED ON SYNTHESIS NATURAL PROGESTERONE AND OESTRADIOL AND PROCESS FOR PREPARING THE SAME
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
JP4354667B2 (en) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト Medicinal combination of ethinylestradiol and drospirenone for use as a contraceptive
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768L (en) * 2000-12-18 2002-06-19 Licentia Oy Enteric-coated pharmaceutical compositions and their preparation
CN1622810A (en) * 2002-03-14 2005-06-01 华生制药公司 Progesterone oral drug delivery system
CN100434133C (en) * 2003-04-29 2008-11-19 欧加农股份有限公司 anti-solvent solidification method
WO2007030153A2 (en) 2005-04-28 2007-03-15 Wyeth Compositions containing micronized tanaproget
EP2055306A1 (en) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Application of a gestagen in combination with an oestrogen and one or more pharmaceutically acceptable excipients/media for lactose-free oral contraception
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
AU2016284459B2 (en) 2015-06-22 2021-12-23 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (en) 1976-11-30 1979-06-08 Besins Jean Louis NEW COMPOSITION WITH ANTI-CONCEPTIONAL ACTION
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
CN1132478A (en) 1996-10-02
LT4043B (en) 1996-09-25
HU9600376D0 (en) 1996-04-29
JPH09501682A (en) 1997-02-18
FI960749L (en) 1996-02-19
HUT74167A (en) 1996-11-28
EP0789560A1 (en) 1997-08-20
KR960703570A (en) 1996-08-31
CZ42596A3 (en) 1996-06-12
LT96010A (en) 1996-06-25
NZ271617A (en) 1996-11-26
PL313113A1 (en) 1996-06-10
FI960749A0 (en) 1996-02-19
BR9407306A (en) 1996-10-08
DK95093D0 (en) 1993-08-20
SK19396A3 (en) 1997-03-05
NO960653D0 (en) 1996-02-19
WO1995005807A1 (en) 1995-03-02
CA2169840A1 (en) 1995-03-02
FI960749A7 (en) 1996-02-19
AU7530594A (en) 1995-03-21

Similar Documents

Publication Publication Date Title
NO960653L (en) A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient
TR199800902T2 (en) Pharmaceutical formulations.
NO934500L (en) Non-klorfluorcarbonaerosolformuleringer
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
MX9201141A (en) CRYSTALLINE CYCLOSPORINS, PROCEDURE FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ATE185562T1 (en) TAXOL DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO2015015I1 (en) Bazedoxifene, optionally in the form of a pharmaceutically acceptable salt such as the acetate salt, and conjugated estrogens.
NO942316D0 (en) Isatin derivatives, processes for their preparation and pharmaceutical compositions comprising such derivatives
IS1812B (en) Therapeutic compounds, pharmaceutically acceptable salts and compositions containing the compounds, together with their use
BR0014312B1 (en) pharmaceutical composition containing a pharmaceutical combination comprising loteprednol and azelastine, medicament and its production process, and use of said combination.
SE9602442D0 (en) Administration of pharmaceuticals
NO992998L (en) New analogues of camptotecin, use as drugs and pharmaceutical compositions containing them
IT8720619A0 (en) 1-(HYDROXYSTYRYL)-5H2,3-BENZODIAZEPE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE94764T1 (en) NASAL APPLICABLE MEDICATION, PROCESS FOR ITS PRODUCTION AND ITS USE.
ITMI912745A1 (en) 5H-BENZODIAZEPINIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THEIR PREPARATION.
ES2192789T3 (en) HYDRAZON-BENZAZULEN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS.
NO20021573L (en) Cross-linked copolymers based on non-cross-linked polycarboxyl copolymers
IT1237429B (en) CYCLIC DERIVATIVES AND THEIR METABOLITES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NO992225L (en) Process for the preparation of salts and esters of clavulanic acid
WO1998014454A3 (en) (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES
DE3867075D1 (en) 2-ALKYLSULFINYL-4 (3H) -QUINAZOLINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS.
NO910186L (en) PROCEDURE FOR THE PREPARATION OF AN ORAL INHALABLE PHARMACEUTICAL ATROPIN-SALBUTAMOL AEROSOL PREPARATION.
IL101456A0 (en) Indole and dihydroquinoline derivatives,and pharmaceutical compositions containing the same
ITMI922954A0 (en) BENZOFURANILIMIDAZOLE DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM
NO911465D0 (en) PROCEDURE FOR THE PREPARATION OF 4- (3- (4-OXOTIAZOLDINYL)) - BUTYNYLAMINES AND THEIR USE AS MEDICINES.